La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Workiva a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Workiva..

Workiva (NYSE:WK) Azioni, Catena delle Opzioni

Workiva

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. It provides to more than 6,000 organizations across the globe with SaaS platform solutions to help solve some of the most complex reporting and disclosure challenges.

Workiva Inc

PT WIJAYA KARYA PERSERO by PT WIJAYA KARYA PERSERO TBK

World Kinect Corp

Wacker Chemie AG

WACKER CHEMIE ORD

WISeKey International Holding Ltd - American Depositary Shares

WISeKey International Holding Ltd

SANDERSON DESIGN GRP PLC by SANDERSON DESIGN GROUP PLC

Sanderson Design Group PLC

WestKam Gold Corp

Workhorse Group Inc

WORKMAN CO LTD ORD by Workman Company Ltd.

Workman Co Ltd

Walker Lane Exploration Inc

Tidal ETF Trust SoFi Weekly Divid ETF

WALKME LTD ORD SHS

WORKSPACE GROUP PLC ORD by Workspace Group Plc.

Workspace Group PLC

WACKER NEUSON SE NAMEN AK by Wacker Neuson SE

Wacker Neuson SE

Worksport Ltd

WEBSKY INC by WebSky, Inc.

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of $0.23 by 8.7 percent. This is a 132.31 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $185.621 million which beat the analyst consensus estimate of $182.577 million by 1.67 percent. This is a 17.35 percent increase over sales of $158.175 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

Workiva Q3 2024 Adj. EPS $0.21 Misses $0.23 Estimate, Sales $185.621M Beat $182.577M Estimate

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) is looking for Q4 Adj EPS of $0.31-0.34 vs $0.34 analyst estimate. seessales of $194.000 million-196.000 million vs $192.36 million estimate.

Guidance

Workiva Sees Q4 Adj EPS $0.31-0.34 vs $0.34 Est; Sees Sales $194.000M-196.000M vs $192.36M Est

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) is looking for Q4 GAAP EPS of $(0.21)-(0.18) vs $(0.15) analyst estimate..

Workiva Sees Q4 GAAP EPS $(0.21)-(0.18) vs $(0.15) Est

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) lowers FY2024 Adj EPS guidance from $0.94-0.98 to $0.93-0.96 vs $0.96 analyst estimate. Raises FY2024 sales outlook from $727.00 million-729.00 million to $733.00 million-735.00 million vs $728.11 million estimate.

Workiva Lowers FY2024 Adj EPS Guidance from $0.94-0.98 to $0.93-0.96 vs $0.96 Est; Raises FY2024 Sales Guidance from $727.00M-729.00M to $733.00M-735.00M vs $728.11M Est

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) narrows FY2024 GAAP EPS guidance from $(1.05)-(1.01) to $(1.05)-(1.02) vs $(0.94) analyst estimate..

Workiva Narrows FY2024 GAAP EPS Guidance from $(1.05)-(1.01) to $(1.05)-(1.02) vs $(0.94) Est

WIIM

ACIW

ADBE

ADEA

ADSK

AEYE

AGYS

AISP

AIXI

ALKT

ANSS

APPF

APPN

ARBK

ASAN

BILL

BLKB

BRZE

BTCM

BTCS

BTCT

CCSI

CIFR

CRWD

CVLT

CWAN

CYBR

DATS

DJCO

DOCU

DOMO

EGAN

EVCM

FICO

FTNT

GRYP

GTLB

HTCR

HUBS

IDAI

IDCC

INTA

INTU

IREN

KVYO

LMFA

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MNDY

MSTR

NCNO

ORCL

PANW

PCOR

PLTR

SDIG

SLNH

SNPS

SOUN

SPNS

SPSC

SSTI

TENB

VRNS

WDAY

XTKG

ZETA

Shares of software companies are trading higher in sympathy with overall market strength after Donald Trump was elected president of the United States.

Northland Capital Markets analyst Mike Grondahl maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Outperform and lowers the price target from $106 to $95.

Price Target

Analyst Ratings

Northland Capital Markets Maintains Outperform on Workiva, Lowers Price Target to $95

Workiva Sees Q3 Adj. EPS $0.22-$0.24 vs $0.25 Est., Tota Revenue $182M-$183M vs $180.48M Est.; Sees FY24 Adj. EPS $0.94-$0.98 vs $0.99 Est., Total Revenue $727M-$729M vs $721.28M Est.

Buybacks

Workiva Authorizes Stock Repurchase Program Of Up To $100M

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) reported quarterly earnings of $0.16 per share which missed the analyst consensus estimate of $0.18 by 11.11 percent. The company reported quarterly sales of $177.503 million which beat the analyst consensus estimate of $175.225 million by 1.30 percent. This is a 14.50 percent increase over sales of $155.022 million the same period last year.

Workiva Q2 2024 Adj. EPS $0.16 Misses $0.18 Estimate, Sales $177.503M Beat $175.225M Estimate

Citigroup analyst Steven Enders maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Buy and raises the price target from $103 to $105.

Citigroup Maintains Buy on Workiva, Raises Price Target to $105

Baird analyst Rob Oliver maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Outperform and lowers the price target from $105 to $94.

Baird Maintains Outperform on Workiva, Lowers Price Target to $94

Workiva Acquires Sustain.Life For $100M; Sustain.Life Becomes Wholly Owned Subsidiary; Equity Awards Adjusted And Escrow Agreement Established

BMO Capital analyst Daniel Jester maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Outperform and maintains $96 price target.

BMO Capital Maintains Outperform on Workiva, Maintains $96 Price Target

U.S. stocks were higher, with the Dow Jones index gaining over 400 points on Friday.
Shares of Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) rose sharply during Friday's session after the company reported better-than-expected first-quarter financial results. Also, the company announced a $50 million milestone <a href="https://www.benzinga.com/general/biotech/24/05/38601856/amgen-reports-better-than-expected-q1-results-50m-milestone-payment">payment from Royalty Pharma</a>.
Amgen reported quarterly earnings of $3.96 per share, which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses driven by the Horizon acquisition, partially offset by higher revenues, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company reported quarterly sales of $7.447 billion, which beat the analyst consensus estimate of $7.436 billion and represents a 21.98% increase over sales of $6.105 billion in the same period last year.
Amgen shares surged 12.2% to $312.45 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Tandem Diabetes Care, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNDM#NASDAQ">TNDM</a>) jumped 27.4% to $46.57 after the comapny reported better-than-expected first-quarter financial results.</li>
<li>WideOpenWest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOW#NYSE">WOW</a>) shares surged 26.1% to $4.7790 after the company received an unsolicited non-binding preliminary proposal from DigitalBridge Investments and various Crestview entities to purchase all of the outstanding shares of WOW! that Crestview does not currently own for $4.80 per share in cash.</li>
<li>El Pollo Loco Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOCO#NASDAQ">LOCO</a>) surged 24.8% to $10.73 after the company reported better-than-expected first-quarter results.</li>
<li>Twist Bioscience Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) jumped 22.8% to $39.31 after the company reported better-than-expected second-quarter financial results.</li>
<li>Alignment Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) surged 22.1% to $6.42 after the company reported better-than-expected first-quarter revenue results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY24 revenue guidance above estimates.</li>
<li>Clearfield, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLFD#NASDAQ">CLFD</a>) surged 21.8% to $38.89 after the company reported better-than-expected second-quarter results and increased its repurchase authorization.</li>
<li>RE/MAX Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMAX#NYSE">RMAX</a>) surged 21% to $8.66 following upbeat quarterly results.</li>
<li>Ardelyx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDX#NASDAQ">ARDX</a>) shares rose 20.7% to $8.19 after the company reported better-than-expected first-quarter financial results.</li>
<li>ModivCare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) rose 19.8% to $26.33 after the company reported better-than-expected quarterly sales results.</li>
<li>OneSpan Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSPN#NASDAQ">OSPN</a>) shares gained 19.6% to $13.09 after the company reported better-than-expected first-quarter adjusted EPS and sales.</li>
<li>IES Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) gained 19% to $162.91 following second-quarter results.</li>
<li>Adtalem Global Education Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NASDAQ">ATGE</a>) rose 16.2% to $60.71 following upbeat quarterly results.</li>
<li>Paylocity Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) gained 16% to $173.49 after the company reported better-than-expected third-quarter financial results and issued FY24 revenue guidance above estimates. The Board of Directors approve a $500 million share repurchase program.</li>
<li>MasTec, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTZ#NYSE">MTZ</a>) surged 14% to $103.86 after the company reported better-than-expected quarterly financial results.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) gained 14% to $45.07.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) gained 11.2% to $9.97 after the company announced it signed an exclusive global arrangement with the Serum Institute of India. The company will be supplied with Bacillus Calmette-Guerin.</li>
<li>MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) surged 10.3% to $1,661.60 after the company reported better-than-expected first-quarter financial results.</li>
<li>Tidewater Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDW#NYSE">TDW</a>) rose 9.8% to $103.13 following upbeat results.</li>
<li>Sunrun Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) gained 9.4% to $11.98.</li>
<li>Enphase Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) rose 9% to $115.59.</li>
<li>Universal Display Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) gained 8.6% to $169.84 after the company reported better-than-expected first-quarter financial results.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) gained 7.4% to $116.96 following better-than-expected first-quarter financial results.</li>
<li>Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) gained 6.7% to $3,705.00 after the company reported better-than-expected first-quarter financial results.</li>
<li>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose 6.4% to $184.09 after the company reported better reported better-than-expected results for its second quarter.</li>
<li>Workiva Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) gained 5.9% to $84.76 following strong quarterly earnings and upbeat EPS guidance.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38613217/top-3-energy-stocks-that-could-blast-off-this-month">Top 3 Energy Stocks That Could Blast Off This Month</a>

Intraday Update

Markets

Movers

AAPL

ALHC

AMGN

ARDX

Adtalem Global Education Inc. Common Stock

ATGE

BKNG

CGON

CLFD

ENPH

IBRX

IESC

LOCO

MELI

MODV

OLED

OSPN

PCTY

RMAX

TNDM

TWST

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday

Workiva shares are trading higher following strong Q1 earnings and upbeat EPS guidance.

Workiva Sees Q2 Adj. EPS $0.16-$0.19 vs $0.13 Est., Total Revenue $174M-$176M vs $177.2M Est.; Sees FY24 Adj. EPS $0.96-$1.03 vs $0.60 Est., Sees Total Revenue $719M-$723M vs $720.8M Est.

Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.17 by 29.41 percent. This is a 283.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $175.667 million which beat the analyst consensus estimate of $174.081 million by 0.91 percent. This is a 16.96 percent increase over sales of $150.189 million the same period last year.

Workiva Q1 2024 Adj EPS $0.22 Beats $0.17 Estimate, Sales $175.667M Beat $174.081M Estimate

Citigroup analyst Steven Enders maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Buy and lowers the price target from $110 to $95.

Citigroup Maintains Buy on Workiva, Lowers Price Target to $95

Workiva: Great Value In This Little-Known Software Vendor

Pegasystems, Intapp and Workiva are Citi's top picks in back office software

ClearBridge Mid Cap Strategy Q3 2024 Commentary

Wolfe's tax loss selling stocks within industrials, tech, materials

Madison Small Cap Fund Q3 2024 Investment Strategy Letter

Here are the major earnings after the close today

Reports Q3 revenue $185.6M, consensus $182.58M. The company said, "Workiva (WK) is once again in a beat and raise position. Our results highlight a...

Workiva reports Q3 EPS 21c, consensus 23c

Sees Q4 revenue $194M-$196M, $192.36M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try No...

Workiva sees Q4 EPS 31c-34c, consensus 34c

workiva Non-GAAP EPS of $0.21 misses by $0.02, revenue of $186M beats by $3.42M

In a report released today, Jake Roberge from William Blair maintained a Buy rating on Workiva (WK – Research Report). The company's shares closed ...

Comments

Workiva

Workiva (WK) Opzioni

Workiva (NYSE:WK) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO